Medicine Quality Alert: Class III Recall of Clindar B (Clindamycin 150mg) Capsules manufactured by Wallace Laboratories Pvt Ltd
The Globe Pharmacy Ltd is recalling batches CBL001CE & CBL002CE of Clindar B capsules due to crumbling and breaking of capsules
From: Pharmacy and Poisons Board
Published: 28th March 2023
Recall Reference Number: REC/2023/002
Recall Classification: Class III
Recall Level: Wholesaler/Distributor Level
Manufacturer: Wallace Laboratories Pvt Ltd, India
Local Technical Representative: Globe Pharmacy Ltd
Product name: Clindar B Capsules
Active Pharmaceutical Ingredient: Clindamycin 150mg
Affected Batches
| Batch Number | Date Of Manufacture | Date Of Expiry | Pack Size |
1. | CBL001CE | 21/05/2022 | 20/05/2025 | 100 capsules |
2. | CBL002CE | 21/05/2022 | 20/05/2025 | 100 capsules |
Brief description of the problem
Globe Pharmacy Ltd is recalling CBL001CE & CBL002CE batches of Clindar B capsules due to the crumbling and breaking of capsules, exposing the contents.
Action for healthcare professionals
Quarantine all remaining stock and stop further distribution, sale, issuing, and use of the affected batches immediately. You will be contacted by Globe Pharmacy Ltd to arrange for the return of the product.
Advice for patients and caregivers
No action is required for patients as this is a wholesaler/distributor level of recall. Patients should continue taking other batches of the product other than the impacted batches and as prescribed by the healthcare professional.
Further Information
For stock enquiries please contact Globe Pharmacy Ltd by email: globe@globe.co.ke or via telephone at +254 701 944 444, +254 775 444 555, +254 775 222 333
You are advised to promptly report any cases of adverse events and suspected substandard and falsified products to the nearest healthcare facility or through the following channels:
- https://pv.pharmacyboardkenya.org/users/mpublic
- USSD code at *271#
- Email pv@ppb.go.ke or pms@ppb.go.ke
- Telephone No. 0795743049
- Mobile application: mPvERS both Android and iOS
For any further information please contact the post-marketing surveillance unit at the Pharmacy and Poisons Board by email: pms@ppb.go.ke
Download document
Medicine Quality Alert: Class III Recall of Clindar B (Clindamycin 150mg)